BRAF and thyroid gland carcinoma: The study using the next-generation sequencing platform for targeted sequencing of selected 341 genes (MSK-IMPACT) in 84 samples of PDTC showed somatic mutations commonly seen in differentiated thyroid cancer such as BRAF p.V600E (33%) and RAS (28%).